PedAM
Pediatric Disease Annotations & Medicines
| Disease | skin disease |
| Phenotype | C0025202|melanoma |
| Sentences | 1 |
| PubMedID- 22397594 | Ipilimumab, marketed as yervoy® by bristol-myers squibb, is the first therapeutic agent which increases survival time in patients with metastatic malignant melanoma, the leading cause of death from skin disease [89]. |
Page: 1